Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report 2024(Status and Outlook)
Report Overview
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
This report provides a deep insight into the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in any manner.
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Market Segmentation (by Type)
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others
Market Segmentation (by Application)
Drug Store
Hospital Pharmacies
Online
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
This report provides a deep insight into the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in any manner.
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Market Segmentation (by Type)
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others
Market Segmentation (by Application)
Drug Store
Hospital Pharmacies
Online
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
- Overview of the regional outlook of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2 Key Market Segments
1.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type
1.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Manufacturers (2019-2024)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Sites, Area Served, Product Type
3.6 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Competitive Situation and Trends
3.6.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) INDUSTRY CHAIN ANALYSIS
4.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2019-2024)
6.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2019-2024)
6.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price by Type (2019-2024)
7 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Sales by Application (2019-2024)
7.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) by Application (2019-2024)
7.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2019-2024)
8 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SEGMENTATION BY REGION
8.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region
8.2 North America
8.2.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche (Genentech)
9.1.1 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.1.2 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.1.4 Roche (Genentech) Business Overview
9.1.5 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
9.1.6 Roche (Genentech) Recent Developments
9.2 Amgen
9.2.1 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.2.2 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 B-MS
9.3.1 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.3.2 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.3.4 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
9.3.5 B-MS Business Overview
9.3.6 B-MS Recent Developments
9.4 Merck
9.4.1 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.4.2 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Recent Developments
9.5 Pfizer
9.5.1 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.5.2 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Novartis
9.6.1 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.6.2 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Eli Lilly and Company
9.7.1 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.7.2 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.7.4 Eli Lilly and Company Business Overview
9.7.5 Eli Lilly and Company Recent Developments
9.8 Johnson and Johnson
9.8.1 Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.8.2 Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.8.3 Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.8.4 Johnson and Johnson Business Overview
9.8.5 Johnson and Johnson Recent Developments
9.9 GSK
9.9.1 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.9.2 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.9.4 GSK Business Overview
9.9.5 GSK Recent Developments
9.10 Sanofi
9.10.1 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.10.2 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.11.2 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.11.4 Boehringer Ingelheim Business Overview
9.11.5 Boehringer Ingelheim Recent Developments
9.12 Zhejiang Jiuzhou Pharmaceutical
9.12.1 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.12.2 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.12.4 Zhejiang Jiuzhou Pharmaceutical Business Overview
9.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
10 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET FORECAST BY REGION
10.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast
10.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country
10.2.3 Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region
10.2.4 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2025-2030)
11.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2025-2030)
11.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Application (2025-2030)
11.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) Forecast by Application
11.2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2 Key Market Segments
1.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type
1.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Manufacturers (2019-2024)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Sites, Area Served, Product Type
3.6 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Competitive Situation and Trends
3.6.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) INDUSTRY CHAIN ANALYSIS
4.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2019-2024)
6.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2019-2024)
6.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price by Type (2019-2024)
7 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Sales by Application (2019-2024)
7.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) by Application (2019-2024)
7.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2019-2024)
8 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SEGMENTATION BY REGION
8.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region
8.2 North America
8.2.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche (Genentech)
9.1.1 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.1.2 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.1.4 Roche (Genentech) Business Overview
9.1.5 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
9.1.6 Roche (Genentech) Recent Developments
9.2 Amgen
9.2.1 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.2.2 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 B-MS
9.3.1 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.3.2 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.3.4 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
9.3.5 B-MS Business Overview
9.3.6 B-MS Recent Developments
9.4 Merck
9.4.1 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.4.2 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Recent Developments
9.5 Pfizer
9.5.1 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.5.2 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Novartis
9.6.1 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.6.2 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Eli Lilly and Company
9.7.1 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.7.2 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.7.4 Eli Lilly and Company Business Overview
9.7.5 Eli Lilly and Company Recent Developments
9.8 Johnson and Johnson
9.8.1 Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.8.2 Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.8.3 Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.8.4 Johnson and Johnson Business Overview
9.8.5 Johnson and Johnson Recent Developments
9.9 GSK
9.9.1 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.9.2 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.9.4 GSK Business Overview
9.9.5 GSK Recent Developments
9.10 Sanofi
9.10.1 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.10.2 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.11.2 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.11.4 Boehringer Ingelheim Business Overview
9.11.5 Boehringer Ingelheim Recent Developments
9.12 Zhejiang Jiuzhou Pharmaceutical
9.12.1 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
9.12.2 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
9.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Market Performance
9.12.4 Zhejiang Jiuzhou Pharmaceutical Business Overview
9.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
10 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET FORECAST BY REGION
10.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast
10.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country
10.2.3 Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region
10.2.4 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2025-2030)
11.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2025-2030)
11.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Application (2025-2030)
11.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) Forecast by Application
11.2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Comparison by Region (M USD)
Table 5. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2022)
Table 10. Global Market Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Sites and Area Served
Table 12. Manufacturers Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Type
Table 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 22. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (K Units)
Table 23. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (M USD)
Table 24. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) by Type (2019-2024)
Table 25. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2019-2024)
Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Type (2019-2024)
Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) by Application
Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2019-2024) & (K Units)
Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2019-2024)
Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2024)
Table 35. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2019-2024) & (K Units)
Table 37. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region (2019-2024)
Table 38. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2019-2024) & (K Units)
Table 41. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2019-2024) & (K Units)
Table 43. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 44. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 45. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche (Genentech) Business Overview
Table 47. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
Table 48. Roche (Genentech) Recent Developments
Table 49. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 50. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 51. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Amgen Business Overview
Table 53. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
Table 54. Amgen Recent Developments
Table 55. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 56. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 57. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
Table 59. B-MS Business Overview
Table 60. B-MS Recent Developments
Table 61. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 62. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 63. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Merck Business Overview
Table 65. Merck Recent Developments
Table 66. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 67. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 68. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pfizer Business Overview
Table 70. Pfizer Recent Developments
Table 71. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 72. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 73. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 77. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 78. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Eli Lilly and Company Business Overview
Table 80. Eli Lilly and Company Recent Developments
Table 81. Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 82. Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 83. Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Johnson and Johnson Business Overview
Table 85. Johnson and Johnson Recent Developments
Table 86. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 87. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 88. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GSK Business Overview
Table 90. GSK Recent Developments
Table 91. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 92. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 93. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Sanofi Business Overview
Table 95. Sanofi Recent Developments
Table 96. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 97. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 98. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Recent Developments
Table 101. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 102. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 103. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 105. Zhejiang Jiuzhou Pharmaceutical Recent Developments
Table 106. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Comparison by Region (M USD)
Table 5. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2022)
Table 10. Global Market Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Sites and Area Served
Table 12. Manufacturers Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Type
Table 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 22. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (K Units)
Table 23. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (M USD)
Table 24. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) by Type (2019-2024)
Table 25. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2019-2024)
Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Type (2019-2024)
Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) by Application
Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2019-2024) & (K Units)
Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2019-2024)
Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2024)
Table 35. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2019-2024) & (K Units)
Table 37. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region (2019-2024)
Table 38. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2019-2024) & (K Units)
Table 41. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2019-2024) & (K Units)
Table 43. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 44. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 45. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche (Genentech) Business Overview
Table 47. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
Table 48. Roche (Genentech) Recent Developments
Table 49. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 50. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 51. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Amgen Business Overview
Table 53. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
Table 54. Amgen Recent Developments
Table 55. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 56. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 57. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) SWOT Analysis
Table 59. B-MS Business Overview
Table 60. B-MS Recent Developments
Table 61. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 62. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 63. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Merck Business Overview
Table 65. Merck Recent Developments
Table 66. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 67. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 68. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pfizer Business Overview
Table 70. Pfizer Recent Developments
Table 71. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 72. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 73. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 77. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 78. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Eli Lilly and Company Business Overview
Table 80. Eli Lilly and Company Recent Developments
Table 81. Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 82. Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 83. Johnson and Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Johnson and Johnson Business Overview
Table 85. Johnson and Johnson Recent Developments
Table 86. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 87. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 88. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GSK Business Overview
Table 90. GSK Recent Developments
Table 91. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 92. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 93. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Sanofi Business Overview
Table 95. Sanofi Recent Developments
Table 96. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 97. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 98. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Recent Developments
Table 101. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Basic Information
Table 102. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
Table 103. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 105. Zhejiang Jiuzhou Pharmaceutical Recent Developments
Table 106. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD), 2019-2030
Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) (2019-2030)
Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (M USD)
Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Share by Manufacturers in 2023
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Manufacturers in 2023
Figure 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type
Figure 18. Sales Market Share of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2019-2024)
Figure 19. Sales Market Share of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type in 2023
Figure 20. Market Size Share of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2019-2024)
Figure 21. Market Size Market Share of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application
Figure 24. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2019-2024)
Figure 25. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application in 2023
Figure 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2024)
Figure 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2023
Figure 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region (2019-2024)
Figure 30. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country in 2023
Figure 32. U.S. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country in 2023
Figure 37. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region in 2023
Figure 44. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (K Units)
Figure 50. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country in 2023
Figure 51. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Type (2025-2030)
Figure 65. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Application (2025-2030)
Figure 66. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD), 2019-2030
Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (M USD) (2019-2030)
Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (M USD)
Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Share by Manufacturers in 2023
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Manufacturers in 2023
Figure 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type
Figure 18. Sales Market Share of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2019-2024)
Figure 19. Sales Market Share of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type in 2023
Figure 20. Market Size Share of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type (2019-2024)
Figure 21. Market Size Market Share of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application
Figure 24. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2019-2024)
Figure 25. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application in 2023
Figure 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2024)
Figure 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2023
Figure 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region (2019-2024)
Figure 30. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country in 2023
Figure 32. U.S. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country in 2023
Figure 37. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region in 2023
Figure 44. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (K Units)
Figure 50. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country in 2023
Figure 51. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Type (2025-2030)
Figure 65. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Application (2025-2030)
Figure 66. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Application (2025-2030)
